According to Bio-Rad Laboratories's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.08808. At the end of 2023 the company had a P/S ratio of 3.52.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.52 | -20.82% |
2022 | 4.44 | -42.18% |
2021 | 7.68 | 12.69% |
2020 | 6.81 | 42.27% |
2019 | 4.79 | 58.7% |
2018 | 3.02 | -8.24% |
2017 | 3.29 | 26.21% |
2016 | 2.61 | 29.42% |
2015 | 2.01 | 24.97% |
2014 | 1.61 | -3.41% |
2013 | 1.67 | 15.56% |
2012 | 1.44 | 10.98% |
2011 | 1.30 | -13.45% |
2010 | 1.50 | 0.72% |
2009 | 1.49 | 28.08% |
2008 | 1.16 | -38.9% |
2007 | 1.91 | 11.06% |
2006 | 1.72 | 18.14% |
2005 | 1.45 | 6.88% |
2004 | 1.36 | -8.7% |
2003 | 1.49 | 36.05% |
2002 | 1.09 | 11.81% |
2001 | 0.9789 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.78 | 22.26% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | 4.82 | 56.19% | ๐บ๐ธ USA |
Agilent Technologies A | 5.76 | 86.61% | ๐บ๐ธ USA |
Becton Dickinson BDX | 3.46 | 11.90% | ๐บ๐ธ USA |
General Electric GE | 2.46 | -20.32% | ๐บ๐ธ USA |
Danaher DHR | 7.33 | 137.26% | ๐บ๐ธ USA |
PerkinElmer
PKI | 4.31 | 39.43% | ๐บ๐ธ USA |